Skip to main content
Jiangsu Apon Medical Technology Co., Ltd. logo

Jiangsu Apon Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300753 ISIN · CNE100003FV4 Shenzhen Stock Exchange Manufacturing
Filings indexed 781 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300753

About Jiangsu Apon Medical Technology Co., Ltd.

https://www.apon.com.cn

Jiangsu Apon Medical Technology Co., Ltd. focuses on the development and production of specialized equipment for pain management and clinical anesthesia. The company’s core offerings include electronic and disposable infusion pumps designed for patient-controlled analgesia (PCA), ensuring precise medication delivery in perioperative settings. Additionally, the firm develops medical sensors and monitoring systems for respiratory and vital sign tracking. Its solutions integrate hardware with software platforms to facilitate digital pain management and improve clinical efficiency. These products are primarily utilized in surgical recovery, labor analgesia, and chronic pain therapy, targeting healthcare providers seeking enhanced patient safety and therapeutic efficacy.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 78% confidence The document is a corporate announcement by Jiangsu Aipeng Medical Technology Co., Ltd. regarding the completion of industrial and commercial change registration and the reissuance of its business license, including detailed license information and business scope. It contains no financial statements, voting results, management changes, dividend declarations, or other event-specific categories (e.g., M&A, share issues). This type of notice does not fit any specialized category and serves as a general regulatory disclosure. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-05-21 Chinese
关于公司高级管理人员减持股份预披露的公告
Director's Dealing Classification · 85% confidence The document is an announcement by a senior management (Vice General Manager Li Qing) of a planned reduction (sale) of his personal shareholding in the company. It details the insider’s shareholding, reduction plan, amounts, timing, commitments, and regulatory compliance — fitting the definition of a director’s/management personal share transaction. Therefore, it is classified as Director’s Dealing (DIRS).
2026-05-20 Chinese
关于股东回馈活动的自愿性信息披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement from Jiangsu Aipeng Medical Technology Co., Ltd. regarding a shareholder appreciation activity. It details the scope of eligible shareholders, the content of the activity (free gifts to shareholders holding 1000 shares or more), registration period, registration method, consultation contact, and a risk warning. The document is short (1086 characters) and does not contain financial statements, audit information, or regulatory certifications. It is not a report but an announcement about a shareholder-related event. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about shareholder information that does not fit other specific categories.
2026-05-19 Chinese
上海君澜律师事务所关于江苏爱朋医疗科技股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2025 Annual General Meeting (AGM) of Jiangsu Aipeng Medical Technology Co., Ltd. It details the convening, procedures, attendance, agenda items, voting results, and legal compliance of the AGM. The document is not the AGM materials or presentations themselves but a legal opinion on the AGM process and results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting outcomes and validates the meeting's legality. The document length (4629 characters) and content confirm it is a detailed legal opinion on the AGM voting results rather than a brief announcement or a full annual report. Therefore, the correct classification is DVA with high confidence.
2026-05-19 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2025 Annual General Meeting Resolution Announcement" for Jiangsu Aipeng Medical Technology Co., Ltd. It details the resolutions passed at the 2025 annual shareholders meeting, including approval of the 2025 annual report, profit distribution plan, changes to the business scope and company bylaws, appointment of auditors, and authorization for stock issuance. It includes voting results, attendance details, and legal opinions confirming the meeting's legality. The document is an official announcement of the voting results from the annual general meeting rather than the full annual report or other detailed financial documents. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4781 characters, which is consistent with a detailed voting results announcement rather than a full report.
2026-05-19 Chinese
第四届董事会第四次会议决议公告
Regulatory Filings Classification · 85% confidence The document is the official announcement of the resolutions passed at the fourth board meeting of Jiangsu Aipeng Medical Technology Co., Ltd. It contains board meeting minutes resolving on various items (e.g., approving reports, profit distribution, auditor appointment, credit facilities, issuance plans, etc.). It does not itself change any board membership (so it’s not a MANG change announcement), nor is it the full annual or interim report. It is a regulatory announcement of board resolutions, fitting the fallback “Regulatory Filings” category.
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.